Skip to main content
. 2021 Jul 14;23(11):2087–2095. doi: 10.1038/s41436-021-01240-8

Table 3.

Melanoma cases with ATM LOF variants in the study cohort.

ID Selection criteria Nucleotide base change Amino acid change Variant effect Cases Cosegregation Total number of melanomas Age at diagnosis of first melanoma Personal history of other cancers Family history of other cancers
NCI_1 S c.717_720del p.Phe239Leufs*15 FS 1 n.d. 1 n.a n.a n.a
NCI_2 S c.6228delT p.Leu2077Phefs*5 FS 1 n.d. 1 n.a n.a n.a
NCI_3 S c.7928-2A>T Splice 1 n.d. 1 n.a n.a n.a
NCI_4 S c.7629 + 2T>C Splice 1 n.d. 1 n.a n.a n.a
NCI_5 S c.902-1G>T Splice 1 n.d. 1 n.a n.a n.a
UNIGE_4 F c.3576G>A p.Ser1135_Lys1195del58 Splice 3 n.d. 2 41 NO NO
UNIGE_22 F c.3576G>A p.Ser1135_Lys1195del58 Splice 2 n.d. 1 49 NO NO
UNIGE_47 F c.3576G>A p.Ser1135_Lys1195del58 Splice 2 Yes (2/2) 2 40 BCC NO
UNIGE_24 F c.4451delT p.Met1484Argfs*15 FS 3 n.d. 3 47 HL, PC CRC, PC
UNIGE_37 F c.8319_8323dupTGTCC p.Pro2775Leufs*33 FS 2 n.d. 3 48 BCC, BC PrC, BCC
UNIGE_39 MPM c.5979_5983delTAAAG p.Ser1993Argfs*23 FS 1 n.d. 3 (1CMM, 2UM) 51 NO NO
UNIGE_40 S c.3275C>A p.Ser1092* NS 1 n.d. 1 47 NO n.a
QIMR_7 F c.1236dup p.Leu413Alafs*17 FS 3 Yes (3/3) n.a 59 NO NO
QIMR_1 F c.7886_7890del p.Ile2629Serfs*25 FS 8 No (1/6) 1 25 NO CRC
QIMR_15 F c.7829_7830del p.Arg2610Lysfs*2 FS 3 Partial (2/3) 12 40 EC CRC, MES
QIMR_16 F c.1236-3_1236-2delinsATTT FS 7 No (1/3) n.a n.a n.a n.a
OUH_8 MPM c.3244_3245insTG p.His1082Leufs*28 FS 1 n.d. 3 72 NO n.a
OUH_13 MPM c.3284 + 1G>A Splice 1 n.d. 3 28 NO n.a
Sanger_7 F c.1561_1562delAG p.Glu522Ilefs*43 FS 5 Partial (3/4) 2 22 n.a BC
Bichat_3 F c.8850 + 2dup Splice 3 n.d. 3 51 CLL n.a

Cosegregation = N cases with a LOF variant/N sequenced cases.

BC  breast cancer, BCC  basal cell cancer, CLL  chronic lymphocytic leukemia, CMM  cutaneous malignant melanoma, CRC  colorectal cancer, EC  endometrial cancer, F  familial melanoma, FS  frameshift variant, HL  Hodgkin lymphoma, LOF  loss of function, MES  mesothelioma, MPM  multiple primary melanoma, n.a. not available, n.d. not determined, NS  nonsense variant, PC  pancreatic cancer, PrC prostate cancer, S sporadic, Splice splice acceptor or splice donor variant, UM  uveal melanoma.